Results 121 to 130 of about 430,558 (143)
Some of the next articles are maybe not open access.
Serum Ca-125 concentrations in endometriosis.
Acta Europaea fertilitatis, 1989Serum Ca-125 levels were measured in 154 patients undergoing laparoscopy or laparotomy for infertility and/or pelvic pain. Pelvic endometriosis at various stages was observed in 102 of the patients, and 52 had a visually normal pelvis and served as a control group.
L. Fedele +5 more
openaire +2 more sources
CA-125 and ovarian hyperstimulation.
Acta Europaea fertilitatis, 1993The ovarian hyperstimulation syndrome (OHSS) has become more and more frequent in relation to the spread of the method of superovulation by means of pharmacologic induction and consequently the necessity of measures suitable for preventing and controlling it has been more and more improved.
L, Scarpellini, F, Scarpellini
openaire +1 more source
Schweizerische medizinische Wochenschrift, 1995
Tumor markers are useful tools in monitoring malignancies postoperatively or under hormone-/chemotherapy. In contrast, they usually lack diagnostic relevance and uncritical use may result in confusing situations. We describe three cases of diagnostic determinations of the tumor marker CA 125 resulting in subsequent partially invasive procedures.
T, Pabst, C, Ludwig
openaire +1 more source
Tumor markers are useful tools in monitoring malignancies postoperatively or under hormone-/chemotherapy. In contrast, they usually lack diagnostic relevance and uncritical use may result in confusing situations. We describe three cases of diagnostic determinations of the tumor marker CA 125 resulting in subsequent partially invasive procedures.
T, Pabst, C, Ludwig
openaire +1 more source
The Netherlands journal of medicine, 1992
The serum tumour marker CA 125 is useful in the management of ovarian cancer, although it has its limitations. Approximately 85% of the ovarian cancer patients have an increased serum CA 125 at the start of treatment. There is a good correlation between the course of CA 125 and the clinical response of the tumour. Patients with an increasing CA 125 are
M E, van der Burg +2 more
openaire +1 more source
The serum tumour marker CA 125 is useful in the management of ovarian cancer, although it has its limitations. Approximately 85% of the ovarian cancer patients have an increased serum CA 125 at the start of treatment. There is a good correlation between the course of CA 125 and the clinical response of the tumour. Patients with an increasing CA 125 are
M E, van der Burg +2 more
openaire +1 more source